Stock Research: Laurus Labs

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Laurus Labs

BSE:540222 INE947Q01028
17
  • Value
    4
  • Growth
    95
  • Safety
    Safety
    3
  • Combined
    6
  • Sentiment
    60
  • 360° View
    360° View
    17
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. It operates in Generics API, Generics FDF, CDMO custom synthesis (Laurus Synthesis), and Biotechnology (Laurus Bio), serving global pharmaceutical, crop science, animal health, regenerative medicine, vaccines, and cultured meat sectors. In the last fiscal year, the company had a market cap of $5164 millions, profits of $315 millions, revenue of $650 millions, and 6167 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 17 (better than 17% compared with alternatives), overall professional sentiment and financial characteristics for the stock Laurus Labs are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Laurus Labs. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 60, which means that professional investors are more optimistic about the stock than for 60% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 3, which means that the share price of Laurus Labs is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 97% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 4, which means that the company has a financing structure that is riskier than those of 96% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
3 15 27 47
Growth
95 97 19 65
Safety
Safety
4 3 9 9
Sentiment
60 57 14 42
360° View
360° View
17 31 1 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
5 3 24 9
Opinions Change
88 81 50 22
Pro Holdings
n/a 43 15 90
Market Pulse
51 56 38 61
Sentiment
60 57 14 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
3 15 27 47
Growth
95 97 19 65
Safety Safety
4 3 9 9
Combined
6 19 1 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 5 15 63
Price vs. Earnings (P/E)
26 46 55 52
Price vs. Book (P/B)
15 28 49 37
Dividend Yield
8 12 15 28
Value
3 15 27 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
92 84 78 89
Profit Growth
92 90 4 12
Capital Growth
35 59 9 67
Stock Returns
100 95 39 65
Growth
95 97 19 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
11 20 26 22
Refinancing
14 12 18 14
Liquidity
18 16 30 45
Safety Safety
4 3 9 9

Similar Stocks

Discover high‑ranked alternatives to Laurus Labs and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

L&T Finance Holdings

BSE:533519
Country: India
Industry: Other Financial Services
Size: Medium
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.